Therapeutic potential of glutathione in cancer management: a meta-analysis

Osman Suliman; Jwaan Abutwaimah; Ahmed Abutwaimah; Raneem Alharbi; Esraa Niazy; Fawzyah Taher; Yara Alhoivi; Atheer Alnuwbi; Raghad Altuwaylie; Sara Altom; Ahmed Abdelmagid

doi:10.18203/2394-6040.ijcmph20260359

Authors

Osman Suliman Department of Surgery, University of Medical Sciences and Technology, Khartoum, Sudan
Jwaan Abutwaimah Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Ahmed Abutwaimah Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Raneem Alharbi Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Esraa Niazy Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Fawzyah Taher Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Yara Alhoivi Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Atheer Alnuwbi Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Raghad Altuwaylie Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Sara Altom Department of Basic Sciences, Al-Rayan National College of Medicine, Al-Rayan National Colleges, Al-Madinah, Saudi Arabia
Ahmed Abdelmagid Department of Emergency, St. George’s Hospital Foundation Trust, London, United Kingdom

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20260359

Keywords:

Glutathione, Cancer therapy, Oxidative stress, Chemoresistance, Antioxidant modulation

Abstract

Glutathione (GSH), a tripeptide and the most abundant intracellular antioxidant, plays a central role in maintaining redox balance, regulating cellular proliferation, and influencing drug resistance in cancer. Its dual role as both a tumor suppressor and a mediator of chemoresistance has generated increasing interest in its therapeutic potential. This meta-analysis aimed to evaluate the role of glutathione and glutathione-modulating strategies in cancer management, with a focus on therapeutic efficacy, mechanisms of action, and clinical outcomes. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Cochrane Library for studies published between 2000 and 2025. Eligible studies included randomized controlled trials, cohort studies, case control studies, and experimental models investigating glutathione supplementation, depletion strategies, or modulation in cancer therapy. Data extraction and quality assessment were performed independently by two reviewers, and findings were synthesized narratively. A total of 25 studies met inclusion criteria, encompassing preclinical and clinical investigations. Glutathione supplementation demonstrated protective effects against chemotherapy-induced toxicity, particularly in cisplatin-related nephrotoxicity and neurotoxicity. Conversely, glutathione depletion strategies, such as buthionine sulfonimine (BSO) and novel inhibitors of glutathione synthesis, enhanced chemosensitivity and reduced tumor proliferation in preclinical models. Clinical trials showed mixed results, with some evidence supporting improved quality of life and reduced treatment-related adverse effects, while others raised concerns regarding potential tumor protection. Glutathione represents a promising but complex therapeutic target in cancer management. Its modulation can either protect normal tissues or sensitize tumors depending on the clinical context, cancer type, and therapeutic regimen. Current evidence highlights both opportunities and challenges, underscoring the need for large, well-designed randomized trials to define standardized protocols for glutathione-based interventions in oncology.

Metrics

Metrics Loading ...

References

Lebedev T, Kousar R, Patrick B, Usama M, Lee MK, Tan M, Li XG. Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells. 2023;12(6):952. DOI: https://doi.org/10.3390/cells12060952

Anderson ME. Glutathione: An overview of biosynthesis and modulation. Chem Biol Interact. 1998;111(112):1-14. DOI: https://doi.org/10.1016/S0009-2797(97)00146-4

Lu SC. Regulation of glutathione synthesis. Mol Aspects Med. 2009;30(1-2):42-59. DOI: https://doi.org/10.1016/j.mam.2008.05.005

Hatem E, El Banna N, Huang ME. Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance. Antioxid Redox Signal. 201720;27(15):1217-34. DOI: https://doi.org/10.1089/ars.2017.7134

Locasale JW. Serine, glycine and one carbon units: Cancer metabolism and redox control. Nat Rev Cancer. 2013;13(8):572-83. DOI: https://doi.org/10.1038/nrc3557

Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato MA, et al. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev. 2013;2013:972913. DOI: https://doi.org/10.1155/2013/972913

Franco R, Cidlowski JA. Glutathione efflux and cell death. Antioxid Redox Signal. 2012;17(12):1694-713. DOI: https://doi.org/10.1089/ars.2012.4553

Liu P, Hao L, Liu M, Hu S. Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy. Front Bioeng Biotechnol. 2023;11:1161472. DOI: https://doi.org/10.3389/fbioe.2023.1161472

Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931-47. DOI: https://doi.org/10.1038/nrd4002

Marini HR, Facchini BA, di Francia R, Freni J, Puzzolo D, Montella L, et al. Glutathione: Lights and Shadows in Cancer Patients. Biomedicines. 2023;11(8):2226.

Kennedy L, Sandhu JK, Harper ME, Cuperlovic-Culf M. Role of Glutathione in Cancer: From Mechanisms to Therapies. Biomolecules. 2020;10(10):1429.

Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci. 2006;43(2):143-81. DOI: https://doi.org/10.1080/10408360500523878

Rocha CR, Garcia CC, Vieira DB, Quinet A, de Andrade-Lima LC, Munford V, et al. Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death Dis. 2015;6(4):e1727. DOI: https://doi.org/10.1038/cddis.2015.101

Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ, Morrison SJ. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527(7577):186-91. DOI: https://doi.org/10.1038/nature15726

Lu SC, Mato JM. S adenosylmethionine in cell growth, apoptosis and liver cancer. J Gastroenterol Hepatol. 2008;23:S73-7. DOI: https://doi.org/10.1111/j.1440-1746.2007.05289.x

Xue X, Wang M, Cui J, Yang M, Ma L, Kang R, et al. Glutathione metabolism in ferroptosis and cancer therapy. Cancer Lett. 2025;621:217697. DOI: https://doi.org/10.1016/j.canlet.2025.217697

Li S, Wang Q, Duan X, Pei Z. Glutathione-responsive PEGlyated nanogel with doxorubicin-conjugation for cancer therapy. J Mater Chem B. 2023;11(7). DOI: https://doi.org/10.1039/D3TB01731A

Zhang H, Montesdeoca N, Tang D, Liang G, Cui M, Xu C, et al. Tumor-targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma. Nat Commun. 2024;15(1):9405. DOI: https://doi.org/10.1038/s41467-024-53646-y

Marini HR, Facchini BA, di Francia R, Freni J, Puzzolo D, Montella L, et al. Glutathione: Lights and Shadows in Cancer Patients. Biomedicines. 2023;11(8):2226. DOI: https://doi.org/10.3390/biomedicines11082226

Desideri E, Ciccarone F, Ciriolo MR. Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy. Nutrients. 2019;11(8):1926. DOI: https://doi.org/10.3390/nu11081926

Ortega AL, Mena S, Estrela JM. Glutathione in cancer cell death. Cancers (Basel). 2011;3(1):1285-310. DOI: https://doi.org/10.3390/cancers3011285

Zorova LD, Semenovich DS, Zorov SD, Oleynikov IP, Kargapoltceva AS, Prutskikh DV, et al. Redox Modulation in Therapy of Cancer: Some Pros and Cons. Antioxidants. 2025;14(12):1496. DOI: https://doi.org/10.3390/antiox14121496

Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217(7):2291-8. DOI: https://doi.org/10.1083/jcb.201804161

Kennedy L, Sandhu JK, Harper M-E, Cuperlovic-Culf M. Role of Glutathione in Cancer: From Mechanisms to Therapies. Biomolecules. 2020;10(10):1429. DOI: https://doi.org/10.3390/biom10101429

Roh JL, Jang H, Kim EH, Shin D. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer. Antioxid Redox Signal. 2017;27(2):106-14. DOI: https://doi.org/10.1089/ars.2016.6841